Article Versions Notes

Kalinovsky DV, Kholodenko IV, Svirshchevskaya EV, Kibardin AV, Ryazantsev DY, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4. Current Issues in Molecular Biology. 2023; 45(10):8112-8125. https://doi.org/10.3390/cimb45100512

Kalinovsky, Daniel V., Irina V. Kholodenko, Elena V. Svirshchevskaya, Alexey V. Kibardin, Dmitry Yu. Ryazantsev, Fedor N. Rozov, Sergey S. Larin, Sergey M. Deyev, and Roman V. Kholodenko. 2023. "Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4" Current Issues in Molecular Biology 45, no. 10: 8112-8125. https://doi.org/10.3390/cimb45100512

Kalinovsky, D. V., Kholodenko, I. V., Svirshchevskaya, E. V., Kibardin, A. V., Ryazantsev, D. Y., Rozov, F. N., Larin, S. S., Deyev, S. M., & Kholodenko, R. V. (2023). Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4. Current Issues in Molecular Biology, 45(10), 8112-8125. https://doi.org/10.3390/cimb45100512